Skip to content

Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients

Inside Liposarcoma Clinical Trials: Patient Experiences Shared While Undergoing Clinical Trials

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06039046
Enrollment
500
Registered
2023-09-15
Start date
2024-10-31
Completion date
2026-10-31
Last updated
2023-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liposarcoma

Keywords

Liposarcoma

Brief summary

The study seeks to delve into the firsthand experiences of patients diagnosed with liposarcoma who partake in a separate clinical research featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. By joining this clinical study, individuals have the unique opportunity to contribute to the betterment of future liposarcoma patients and play an active role in advancing medical research.

Interventions

None listed

Sponsors

Power Life Sciences Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient has self-identified as planning to enroll in a clinical research * Patient has been diagnosed with liposarcoma * Patient is a minimum of 18 years or older

Exclusion criteria

* Patient does not understand, sign, and return consent form * Inability to perform regular electronic reporting * Patient is pregnant

Design outcomes

Primary

MeasureTime frame
Number of patients who decide to participate in a liposarcoma clinical study3 months
Rate of patients who remain in liposarcoma clinical study to trial completion12 months

Countries

United States

Contacts

Primary ContactMichael B Gill
bask@withpower.com4159004227

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026